RE:ATHERONOVA REVERSE STOCK SPLIT INTERESTING NOTE
Ive been following this one for quite a while now. Its basically a bile acid which acts as a detergent for lipids. It's interesting. They are doing their clinical work in Russia which isn't a shock as a couple years ago some Russian VC forms where throwing around a lot of money to small US biotechs. This certainly will be competitive to RVX if it works and is approved. My main issue with this company and this compound is that they put out fantastic pre-clinical data. Something like 95% plaque regression. However they stated nothing about the animal model, dosing, duration, how they measured regression, etc. You just can't put that kind of a number out without providing additional details and expect to betaken seriously. It reminds me of some of the stem cell plays that I follow.